These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


376 related items for PubMed ID: 22079717

  • 1. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
    Rabišková M, Bautzová T, Gajdziok J, Dvořáčková K, Lamprecht A, Pellequer Y, Spilková J.
    Int J Pharm; 2012 Jan 17; 422(1-2):151-9. PubMed ID: 22079717
    [Abstract] [Full Text] [Related]

  • 2. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, Merlin D.
    Gastroenterology; 2010 Mar 17; 138(3):843-53.e1-2. PubMed ID: 19909746
    [Abstract] [Full Text] [Related]

  • 3. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
    Bautzová T, Rabišková M, Béduneau A, Pellequer Y, Lamprecht A.
    Eur J Pharm Biopharm; 2012 Jun 17; 81(2):379-85. PubMed ID: 22386911
    [Abstract] [Full Text] [Related]

  • 4. Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis.
    Crcarevska MS, Dodov MG, Petrusevska G, Gjorgoski I, Goracinova K.
    J Drug Target; 2009 Dec 17; 17(10):788-802. PubMed ID: 19938950
    [Abstract] [Full Text] [Related]

  • 5. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S, Kruenate J, Prahsarn C.
    Int J Pharm; 2006 Apr 07; 312(1-2):113-8. PubMed ID: 16490331
    [Abstract] [Full Text] [Related]

  • 6. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
    Pertuit D, Moulari B, Betz T, Nadaradjane A, Neumann D, Ismaïli L, Refouvelet B, Pellequer Y, Lamprecht A.
    J Control Release; 2007 Nov 20; 123(3):211-8. PubMed ID: 17889397
    [Abstract] [Full Text] [Related]

  • 7. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J, Podczeck F, Newton JM.
    Int J Pharm; 2004 May 04; 275(1-2):41-60. PubMed ID: 15081137
    [Abstract] [Full Text] [Related]

  • 8. Stability testing of alginate-chitosan films.
    Rabisková M, Dvorácková K, Kofronvá L.
    Ceska Slov Farm; 2012 Feb 04; 61(1-2):26-33. PubMed ID: 22536650
    [Abstract] [Full Text] [Related]

  • 9. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C, Nácher A, Merino V, Merino-Sanjuan M, Carda C, Ruiz A, Manconi M, Loy G, Fadda AM, Diez-Sales O.
    Int J Pharm; 2011 Sep 15; 416(1):145-54. PubMed ID: 21723929
    [Abstract] [Full Text] [Related]

  • 10. Optimization of budesonide compression-coated tablets for colonic delivery.
    Yehia SA, Elshafeey AH, Sayed I, Shehata AH.
    AAPS PharmSciTech; 2009 Sep 15; 10(1):147-57. PubMed ID: 19199041
    [Abstract] [Full Text] [Related]

  • 11. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
    Oshi MA, Naeem M, Bae J, Kim J, Lee J, Hasan N, Kim W, Im E, Jung Y, Yoo JW.
    Carbohydr Polym; 2018 Oct 15; 198():434-442. PubMed ID: 30093020
    [Abstract] [Full Text] [Related]

  • 12. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
    Shariff A, PK M, KLK P, M M.
    Pak J Pharm Sci; 2007 Jan 15; 20(1):1-9. PubMed ID: 17337420
    [Abstract] [Full Text] [Related]

  • 13. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats.
    Onishi H, Koyama K, Sakata O, Machida Y.
    Drug Dev Ind Pharm; 2010 Aug 15; 36(8):879-84. PubMed ID: 20345284
    [Abstract] [Full Text] [Related]

  • 14. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y, Wei W, Lv P, Wang L, Ma G.
    Eur J Pharm Biopharm; 2011 Jan 15; 77(1):11-9. PubMed ID: 20933083
    [Abstract] [Full Text] [Related]

  • 15. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
    Smrdel P, Cerne M, Bogataj M, Urleb U, Mrhar A.
    J Microencapsul; 2010 Jan 15; 27(7):572-82. PubMed ID: 20690794
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
    Onishi H, Oosegi T, Machida Y.
    Int J Pharm; 2008 Jun 24; 358(1-2):296-302. PubMed ID: 18394832
    [Abstract] [Full Text] [Related]

  • 17. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis.
    Duan H, Lü S, Qin H, Gao C, Bai X, Wei Y, Wu X, Liu M, Zhang X, Liu Z.
    Int J Pharm; 2017 Jan 10; 516(1-2):214-224. PubMed ID: 27851980
    [Abstract] [Full Text] [Related]

  • 18. Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation.
    Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P.
    Acta Pharm; 2012 Nov 10; 62(3):341-56. PubMed ID: 23470347
    [Abstract] [Full Text] [Related]

  • 19. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B, Ferreira DC, Jorgensen L, van de Weert M.
    Eur J Pharm Biopharm; 2007 Jan 10; 65(1):10-7. PubMed ID: 17101268
    [Abstract] [Full Text] [Related]

  • 20. Mucoadhesive platforms for targeted delivery to the colon.
    Varum FJ, Veiga F, Sousa JS, Basit AW.
    Int J Pharm; 2011 Nov 25; 420(1):11-9. PubMed ID: 21856393
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.